The art of prevention: COVID-19 vaccine preparedness for the dermatologist.
Int J Womens Dermatol
; 7(2): 209-212, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-1019115
ABSTRACT
As COVID-19 vaccinations begin, dermatologists must be aware of the cutaneous adverse events reported in the clinical trials, including injection site and hypersensitivity reactions, and emerging evidence of dermal filler injection reactions after vaccination. The filler reaction may represent the development of a delayed-type hypersensitivity in the setting of another immunologic trigger (i.e., the vaccine). After conducting a literature review of similar reactions, their pathophysiology, and management, we present a set of timely clinical considerations for counseling, prevention, and management of possible cutaneous sequelae of the COVID-19 vaccine. We encourage documentation of vaccine-related reactions to aid the safety data collection in the Vaccine Adverse Event Reporting System and the American Academy of Dermatology COVID-19 Registry.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
/
Reviews
Topics:
Long Covid
/
Vaccines
Language:
English
Journal:
Int J Womens Dermatol
Year:
2021
Document Type:
Article
Affiliation country:
J.ijwd.2021.01.007
Similar
MEDLINE
...
LILACS
LIS